Skip to content
LaunchIndex
Browse/2026/09/skincare-plus.com

여드름·로사세아·모낭염 질환정보 | 수란트라, 디페린, 이소티논, 미노씬, 이버멕틴, 아다팔렌, 아젤라익산, 미노사이클린, 독시사이클린, 이소트레티노인

skincare-plus.com

LaunchIndex first observed 여드름·로사세아·모낭염 질환정보 | 수란트라, 디페린, 이소티논, 미노씬, 이버멕틴, 아다팔렌, 아젤라익산, 미노사이클린, 독시사이클린, 이소트레티노인 (skincare-plus.com) live on 13 September 2026. View its launch screenshot, category, technologies, and verification evidence.

Screenshot of skincare-plus.com
Captured September 13, 2026 18:21 as part of the recorded launch evidence.
Observed launch story

A launch record built from evidence.

여드름·로사세아·모낭염 질환정보 | 수란트라, 디페린, 이소티논, 미노씬, 이버멕틴, 아다팔렌, 아젤라익산, 미노사이클린, 독시사이클린, 이소트레티노인 (skincare-plus.com) was first observed live on 13 September 2026.

Skincare guide offering information on acne, rosacea, folliculitis, and related treatment ingredients (e.g., ivermectin, adapalene, azelaic acid, minocycline, doxycycline, isotretinoin) with product comparisons.

Its profile is classified as Media within Health / Health and wellness. Verification detected Google Analytics.

Recorded evidence

What the launch signal contained.

First observed live
Previous state
No prior non-live observation
Last verified
Canonical host
skincare-plus.com
Category
Health / Health and wellness
Website type
Media
Observed title
여드름·로사세아·모낭염 질환정보 | 수란트라, 디페린, 이소티논, 미노씬, 이버멕틴, 아다팔렌, 아젤라익산, 미노사이클린, 독시사이클린, 이소트레티노인
Observed description
여드름, 로사세아, 주사피부염, 모낭염과 관련해 사용되는 이버멕틴, 아다팔렌, 아젤라익산, 미노사이클린, 독시사이클린, 이소트레티노인 성분 정보 및 수란트라크림, 디페린겔, 아젤리아크림, 미노씬, 이소티논 등과 동일 성분 제품들의 정보를 한눈에 확인하세요.
Detected technologies
Google Analytics
Screenshot captured
Evidence source
Browser observation · Local
Evidence confidence
93%
HTTP status
200
Website owner

Is this your website?

Claim this profile to add verified owner information.

Claim website
Community signal

What do you make of this launch?

Vote on the site and leave a short note for other people exploring the new web.

↑0Up
↓0Down

Join the discussion

Sign in with Google to vote or comment.

Sign in to participate

Comments

0 comments
No comments yet

Be the first to leave a useful observation.

Report an issueFlag spam, illegal or harmful content, or inaccurate information.

Reports are private and reviewed by the moderation team. No sign-in is required, so this report will be anonymous.

Private to moderators · 10–2,000 characters